The board of directors at Intrommune has a history of experience with oncology and biosciences. The current Chief Financial Officer has a background in molecular oncology and Epigenetics from the Icahn School of Medicine at Mount Sinai. The Head of Corporate Development has a degree in Chemistry and Classics from Harvard University.
View all